Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,314
Out of 5,090 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $27.91 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $74.97 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $304.49 | +5.09% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $101.36 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $39.86 | +20.42% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $141.68 | - | 4 | Apr 16, 2019 | |
| HSDT Solana Company | Downgrades: Neutral | n/a | $3.86 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $178.37 | -55.15% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $11.90 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $101.06 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $125.08 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $97.52 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $65.49 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $86.19 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $27.91
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $74.97
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $304.49
Upside: +5.09%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $101.36
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $39.86
Upside: +20.42%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $141.68
Upside: -
Solana Company
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $3.86
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $178.37
Upside: -55.15%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $11.90
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $101.06
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $125.08
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $97.52
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $65.49
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $86.19
Upside: -